AzTrials
AzTrials

MyopiaNCT04658797

Clinical Evaluation on Using Personal Face Masks With Spectacles Versus Contact Lenses

A study testing somofilcon A Daily Disposable Contact Lens, Single Vision Spectacle for Vision Correction and Personal Facemask in people with Myopia, run by CooperVision, Inc. at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to explore satisfaction with vision correction and ease of use of PFM (Personal Face Masks) in a group of spectacle wearers who were randomised to continue wearing spectacles or be fitted with daily disposable contact lenses. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Myopia
What is being tested?
somofilcon A Daily Disposable Contact Lens, Single Vision Spectacle for Vision Correction and Personal Facemask
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
1 Nov 2020to 30 Apr 2021
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • They are aged between 18 and 40 years.
  • They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They are a 'neophyte' (i.e. someone who has not worn contact lenses previously, with the exception for the purposes of a trial fitting).
  • They have a contact lens spherical prescription between +8.00D and -10.00D (inclusive) based on the ocular refraction.
  • They have a cylindrical correction of -0.75DC or less in each eye based on the ocular refraction.
Show all 12Show fewer
  • They own and habitually wear single vision spectacles.
  • They are willing to be fitted with contact lenses and understand they may be randomised to either group.
  • They are willing to wear the contact lenses (if relevant) or spectacles for at least 8 hours per day, 5 days per week.
  • They are able to wear the supplied surgical masks for the majority of time that they need to wear PFM and will wear the PFM for at least one hour a day for at least four days per week.
  • They can attain at least 0.20 logMAR distance high contrast visual acuity in each eye with the study lenses (if relevant) or spectacles.
  • They agree to not participate in other clinical research while enrolled on this study.

Who cannot join

  • They have an ocular disorder which would normally contra-indicate contact lens
  • wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops or ointment.
  • They have had cataract surgery.
  • They have had corneal refractive surgery.
Show all 13Show fewer
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They are pregnant or breastfeeding.
  • They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
  • They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
  • They require significant ocular/face personal protective equipment beyond a personal face mask.
  • They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.
  • They have spectacles which are not within ±0.50D of their refractive error.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Eurolens Research

    Manchester, M13 9PL

Other trials in United Kingdom

About this study

The aim of this study was to explore satisfaction with vision correction and ease of use of PFM (Personal Face Masks) in a group of spectacle wearers who were randomised to continue wearing spectacles or be fitted with daily disposable contact lenses.

Read the detailed description

This was a two arm parallel-group, randomised study. Subjects wearing single vision spectacles were recruited to participate in the study. Subjects were randomised to either continue to use their spectacles or to be fitted with the study daily disposable (DD) contact lens.

Conditions
Myopia
Being tested
somofilcon A Daily Disposable Contact Lens, Single Vision Spectacle for Vision Correction, Personal Facemask
Medical subject headings
Myopia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • somofilcon A Daily Disposable Contact LensDevice

    Daily Disposable Contact Lens

  • Single Vision Spectacle for Vision CorrectionDevice

    Single Vision Spectacle

  • Personal FacemaskOther

    Personal Facemask

Study groups in NCT04658797
Study groupRoleWhat they receive
Single Vision Spectacle for Vision correctionActive comparatorSingle Vision Spectacle
Receives: Device: Single Vision Spectacle for Vision Correction; Other: Personal Facemask
somofilcon A Daily disposable contact lensesExperimentalDaily disposable contact lenses
Receives: Device: somofilcon A Daily Disposable Contact Lens; Other: Personal Facemask

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Acuity - High Contrast

    Visual Acuity under high contrast was measured using logMAR Visual Acuity Chart

    Measured: Baseline

  2. Visual Acuity - Low Contrast

    Visual Acuity under low contrast was measured using logMAR Visual Acuity Chart

    Measured: Baseline

  3. Visual Acuity - High Contrast

    Visual Acuity under high contrast was measured using logMAR Visual Acuity Chart

    Measured: 2 weeks

  4. Subjective Response on Facemask Usability Questionnaire - Breathability

    Subjective response on facemask usability questionnaire - Breathability assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: Baseline

  5. Subjective Response on Facemask Usability Questionnaire - Breathability

    Subjective response on facemask usability questionnaire - Breathability assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: 2 weeks

  6. Subjective Response on Facemask Usability Questionnaire - Heat

    Subjective response on facemask usability questionnaire - Heat assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: Baseline

  7. Subjective Response on Facemask Usability Questionnaire -Heat

    Subjective response on facemask usability questionnaire - Heat assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: 2 weeks

  8. Subjective Response on Facemask Usability Questionnaire - Tightness

    Subjective response on facemask usability questionnaire - Tightness assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: Baseline

  9. Subjective Response on Facemask Usability Questionnaire -Tightness

    Subjective response on facemask usability questionnaire - Tightness assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: 2 weeks

  10. Subjective Response on Facemask Usability Questionnaire - Ease in Talking

    Subjective response on facemask usability questionnaire - Ease in Talking assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: Baseline

  11. Subjective Response on Facemask Usability Questionnaire -Ease in Talking

    Subjective response on facemask usability questionnaire - Ease in Talking assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: 2 weeks

  12. Subjective Response on Facemask Usability Questionnaire - Comfort on Ear Lobes

    Subjective response on facemask usability questionnaire - Comfort on ear lobes assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: Baseline

  13. Subjective Response on Facemask Usability Questionnaire - Comfort on Ear Lobes

    Subjective response on facemask usability questionnaire - Comfort on ear lobes assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: 2 Weeks

  14. Subjective Response on Facemask Usability Questionnaire - Overall Comfort

    Subjective response on facemask usability questionnaire - Overall Comfort assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: Baseline

  15. Subjective Response on Facemask Usability Questionnaire - Overall Comfort

    Subjective response on facemask usability questionnaire - Overall Comfort assessed on a 5 point scale (1- very unsatisfactory, 2- Unsatisfactory, 3- Average, 4- Satisfactory, 5- Very Satisfactory)

    Measured: 2 Weeks

  16. Difficulty in Walking When Using Wearing Vision Correction and Facemask

    Difficulty in walking when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy).

    Measured: Baseline

  17. Difficulty in Walking When Using Wearing Vision Correction and Facemask

    Difficulty in walking when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: 2 Weeks

  18. Difficulty in Driving When Using Wearing Vision Correction and Facemask

    Difficulty in driving when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: Baseline

  19. Difficulty in Driving When Using Wearing Vision Correction and Facemask

    Difficulty in driving when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: 2 weeks

  20. Difficulty in Reading When Using Wearing Vision Correction and Facemask

    Difficulty in reading when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: Baseline

  21. Difficulty in Reading When Using Wearing Vision Correction and Facemask

    Difficulty in reading when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: 2 weeks

  22. Difficulty in Working With a Computer When Using Wearing Vision Correction and Facemask

    Difficulty in working with a computer when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: Baseline

  23. Difficulty in Working With a Computer When Using Wearing Vision Correction and Facemask

    Difficulty in working with a computer when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: 2 weeks

  24. Difficulty in Exercising (Physical Activities) When Using Wearing Vision Correction and Facemask

    Difficulty in exercising (physical activities)when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: Baseline

  25. Difficulty in Exercising (Physical Activities) When Using Wearing Vision Correction and Facemask

    Difficulty in exercising (physical activities)when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: 2 weeks

  26. Difficulty in Socializing When Using Wearing Vision Correction and Facemask

    Difficulty in socializing when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: Baseline

  27. Difficulty in Socializing When Using Wearing Vision Correction and Facemask

    Difficulty in socializing when using wearing vision correction and facemask assessed on a scale of 1-5 (1- very difficult, 2- difficult, 3- Neutral, 4, Easy, 5- Very Easy)

    Measured: 2 weeks

  28. Physical Safety Concerns When Wearing Your Vision Correction and Facemask

    Physical safety concerns when wearing your vision correction and facemask assessed on a scale of 1-5 (1- Extremely concerned, 2 - Moderately concerned, 3- Somewhat concerned, 4 -Slightly concerned, 5- Not at all concerned)

    Measured: Baseline

  29. Physical Safety Concerns When Wearing Your Vision Correction and Facemask

    Physical safety concerns when wearing your vision correction and facemask assessed on a scale of 1-5 (1- Extremely concerned, 2 - Moderately concerned, 3- Somewhat concerned, 4 -Slightly concerned, 5- Not at all concerned)

    Measured: 2 weeks

  30. Emotional Impact of Using the Facemask When Wearing Your Vision Correction

    Emotional impact of using the facemask when wearing your vision correction assessed on a scale of 1-5 (1- Severe, 2- Major, 3- Moderate, 4- Minor, 5- Insignificant)

    Measured: Baseline

  31. Emotional Impact of Using the Facemask When Wearing Your Vision Correction

    Emotional impact of using the facemask when wearing your vision correction assessed on a scale of 1-5 (1- Severe, 2- Major, 3- Moderate, 4- Minor, 5- Insignificant)

    Measured: 2 weeks

  32. Impact of Using the Facemask on Your Personal Appearance When Wearing Your Vision Correction

    Impact of using the facemask on your personal appearance when wearing your vision correction assessed on a scale of 1-5 (1- Severe, 2- Major, 3- Moderate, 4- Minor, 5- Insignificant)

    Measured: Baseline

  33. Impact of Using the Facemask on Your Personal Appearance When Wearing Your Vision Correction

    Impact of using the facemask on your personal appearance when wearing your vision correction assessed on a scale of 1-5 (1- Severe, 2- Major, 3- Moderate, 4- Minor, 5- Insignificant)

    Measured: 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2020 (estimated)
  2. Study start1 Nov 2020
  3. Primary completion15 Apr 2021
  4. Study completion30 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04658797
Sponsor's protocol ID
C20-688 (EX-MKTG-120)
Status last verified
Sep 2021
First submitted
1 Dec 2020
Last updated
20 Oct 2021
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing somofilcon A Daily Disposable Contact Lens, Single Vision Spectacle for Vision Correction and Personal Facemask in people with Myopia, run by CooperVision, Inc. at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 12 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Oct 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 20 Oct 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Acuity - High Contrast (time frame: Baseline). The study lists 33 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Oct 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in